Literature DB >> 7696158

DNA-minor-groove alkylators, a new class of anticancer agents.

M D'Incalci.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7696158     DOI: 10.1093/oxfordjournals.annonc.a058724

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cells.

Authors:  M Ghielmini; G Bosshard; L Capolongo; M C Geroni; E Pesenti; V Torri; M D'Incalci; F Cavalli; C Sessa
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.

Authors:  A Awada; C J Punt; M J Piccart; O Van Tellingen; L Van Manen; J Kerger; Y Groot; J Wanders; J Verweij; D J Wagener
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

3.  Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.

Authors:  S Marchini; M Cirò; F Gallinari; C Geroni; P Cozzi; M D'Incalci; M Broggini
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

4.  Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.

Authors:  A Fedier; C Fowst; J Tursi; C Geroni; U Haller; S Marchini; D Fink
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.